ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2022 | $910,000 | Replaced |
| 3rd Quarter - Amendment | Nov 7, 2022 | $930,000 | Yes |
What was lobbied
9 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1730/S. 670- Speeding Therapy Access Today Act; H.R. 483/S. 350 - Newborn Screening Saves Lives Act; H.R. 6000 Cures 2.0 Act; H.R. 6584 Diverse and Equitable Participation in Clinical Trials Act; S. 2706/H.R. 5030 Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act; H.R. 6963 - Accelerated Approval Integrity Act; H.R. 6996 - Accelerating Access for Patients Act - General issues related to rare disease and orphan drugs; General issues related to drug pricing; Reauthorization of the FDA User Fee Act; FDA modernization policy issues; Reauthorization of newborn screening programs; Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients; General issues related to health equity in rare disease and clinical trials; General issues related to diagnostics for patients with rare diseases Cancer screening, diagnosis & treatment Prescription drug electronic labeling H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 - Lower Costs, More Cures Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 - Build Back Better Act; H.R. 7667 - Food and Drug Amendments of 2022; S.4348 - FDASLA Act of 2022 H.R. 7845 - NIH Clinical Trial Diversity Act of 2022; H.R 7032 - Increasing Transparency in Generic Drug Applications Act of 2022; H.R. 2883, Stop Stalling Access to Affordable Medications Issues related to COVID-19 vaccines and therapies; Items related to the Administrations Cancer Moonshot Prescription Drug User Fee Act (PDUFA) H.R. 4128/S. 2209, VALID Act S. 4293, the Pharmacy Benefit Manager Transparency Act of 2022 Pharmaceutical Innovation, generally;
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| ELIZABETH BROOKS | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER | — |
| KATIE JONES | — |
| CAROLINE QUAT | — |
Medicare/Medicaid MMM
H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act; H.R. 19 - Lower Costs, More Cures Act; H.R. 5260 - Reduced Costs and Continued Cures Act; H.R. 5376 - The Inflation Reduction Act of 2022; General issues related to patient access to rare disease therapies, Part B and Part D drugs; Issues related to home infusion for Part B patients; Center for Medicare and Medicaid Innovation (CMMI) policy issues; Value-based payment arrangements; Efforts to improve coding, coverage, and access for rare disease therapies; Issues related to low volume Diagnosis Related Groups (DRGs) and rare therapies; General issues related to diagnostic reimbursement S. 1873/H.R. 1946 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 Issues related to preventative services and screenings for underrepresented communities H.R 4065/S. 1971 (Section 101) - Expanding Medicare annual wellness benefit to include kidney disease screening CMS Comment Solicitation on Possible Mechanisms to Address Rare Diseases and Conditions Represented by Low Volumes within the MS-DRG Structure General issues related to diagnostic reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| ELIZABETH BROOKS | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER | — |
| KATIE JONES | — |
| CAROLINE QUAT | — |
Pharmacy PHA
H.R. 7559 and issues related to an appropriations hold on funding for a 2014 FDA rule that would provide electronic flexibilities related to package inserts Issues related to the 340B drug discount program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| ELIZABETH BROOKS | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER | — |
| KATIE JONES | — |
| CAROLINE QUAT | — |
Trade (domestic/foreign) TRD
H.R. 2873, the Affordable Prescriptions for Patients Through Promoting Competition Act H.R. 2884, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act H.R. 2883, Stop Stalling Access to Affordable Medications H.R. 2891 Preserve Access to Affordable Generics and Biosimilars Act H.R. 4521, H. Rept. 117-235 America COMPETES Act of 2022 H.R. 7032, Increasing Transparency in Generic Drug Applications Act of 2022 S. 1435, the Affordable Prescriptions for Patients Act S. 1425, Stop STALLING Act Issues related to the World Trade Organization (WTO) waiver on Trade-related Aspects of Intellectual Property Rights (TRIPS) for COVID-19 vaccines
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| ELIZABETH BROOKS | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER | — |
| KATIE JONES | — |
| CAROLINE QUAT | — |
Taxation/Internal Revenue Code TAX
H.R. 2623 - Camerons Law H.R. 5376 - Build Back Better Act Issues related to the Orphan Drug Tax Credit Issues related to the deduction of research and development expenditures Issues related to corporate and international tax reform S. 749/H.R 1304 - American Innovation and Jobs Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| ELIZABETH BROOKS | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER | — |
| KATIE JONES | — |
| CAROLINE QUAT | — |
Budget/Appropriations BUD
Appropriations, FY 2023; H.R 8239, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023 H.R. 6833, P.L 117-180, Affordable Insulin Now Act H.R. 8294, ransportation, Housing and Urban Development, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, and Veterans Affairs Appropriations Act, 2023 H.R. 8295/S. 4659, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| ELIZABETH BROOKS | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER | — |
| KATIE JONES | — |
| CAROLINE QUAT | — |
Copyright/Patent/Trademark CPT
Issues related to intellectual property, data exclusivity, patent eligibility & patent law reform S. 4417, the PTAB Reform Act TRIPS IP Waiver Issues related to manufacturer patent protections at the World Health Organization
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| ELIZABETH BROOKS | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER | — |
| KATIE JONES | — |
| CAROLINE QUAT | — |
Environment/Superfund ENV
Sustainability & Zero Carbon; Items related to environmental sustainability and our Ambition Zero Carbon efforts
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| ELIZABETH BROOKS | — |
| HELEN DWIGHT | — |
| THADDEUS FLOOD | — |
| AARON W HUNTER | — |
| KATIE JONES | — |
| CAROLINE QUAT | — |
Foreign Relations FOR
Amendment to Montreal Protocol ("Kigali Amendment")
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH CUDWORTH ARBES New | Asst Secretary for Legislation, Dept of Health and Human Services; Principal Deputy Assistant Secretary for Legislation, Dept of Health and Human Services; Deputy Health Policy Director, U.S. Senate Committee on Health, Education, Labor and Pension |
| CAROLINE QUAT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.